Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Eli Lilly presents novel aldosterone synthase inhibitors

Jan. 15, 2013

Mirabegron approved in Europe

Jan. 14, 2013

OPKO Health to expand pipeline with acquisition of Cytochroma

Jan. 11, 2013

Phase I RenaZorb data support further development

Jan. 10, 2013

Japan Tobacco files JTT-751 NDA in Japan

Jan. 8, 2013

Proteon Therapeutics reports results from study of recombinant human elastase

Jan. 7, 2013

TheraVida reports topline Tolenix data in overactive bladder and urinary incontinence

Jan. 4, 2013

Relypsa reaches agreement with FDA for phase III trial of patiromer

Jan. 3, 2013

FDA accepts supplemental BLA filing for Xiaflex

Dec. 31, 2012

FDA approves La Jolla Pharmaceutical's IND for CKD drug

Dec. 7, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...